Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis

Links shared publicly online about this topic.

434
total visits

Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis

Cyclophosphamide (cy) is an alkylating agent used to treat malignancies and immune-mediated inflammatory nonmalignant processes. It has been used as a treatment in cases of worsening multiple sclerosis (MS). Cy is currently used for patients whose disease is not controlled by beta-interferon or glatiramer acetate as well as those with rapidly worsening MS. The most commonly used regimens involve outpatient IV pulse therapy given with or without corticosteroids every 4 to 8 weeks. Side effects in

View full resource at sage-hindawi.com

Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Malignancy, Disease and Condition, Healthcare, Copaxone, disease